Advanced search
Publication Cover
mAbs Volume 12, 2020 - Issue 1
Submit an article Journal homepage
3,749
Views
11
CrossRef citations to date
0
Altmetric
Report

A general evidence-based sequence variant control limit for recombinant therapeutic protein development

Aming Zhanga Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USACorrespondence[email protected]
,
Zhengwei Chena Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA
,
Meinuo Lia Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA
,
Haibo Qiua Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8449-4233
ORCID Icon,
Shawn Lawrenceb Preclinical Manufacturing and Process Development, Tarrytown, New York, USA
,
Hanne Bakb Preclinical Manufacturing and Process Development, Tarrytown, New York, USA
&
Ning Lia Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA
 show all
Article: 1791399 | Received 18 Mar 2020, Accepted 08 Jun 2020, Published online: 02 Aug 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.